Based on the strong in vitro data which supported the use of iNOP-7-PLK1 siRNA to reduce NSCLC cell growth, we next investigated the potential of iNOP-7-PLK1 siRNA to reduce lung tumor growth in a clinically-relevant orthotopic NSCLC mouse model. This evidence concerns the gene PLK1 and non-small cell lung carcinoma.